{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:57:02Z","timestamp":1792652222013,"version":"4.5.0"},"reference-count":133,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Because of the high demand of organs, the usage of marginal grafts has increased. These marginal organs have a higher risk of developing ischemia-reperfusion injury, which can lead to posttransplant complications. Ex situ machine perfusion (MP), compared with the traditional static cold storage, may better protect these organs from ischemia-reperfusion injury. In addition, MP can also act as a platform for dynamic administration of pharmacological agents or gene therapy to further improve transplant outcomes. Numerous therapeutic agents have been studied under both hypothermic (1\u20138\u00b0C) and normothermic settings. Here, we review all the therapeutics used during MP in different organ systems (lung, liver, kidney, heart). The major categories of therapeutic agents include vasodilators, mesenchymal stem cells, antiinflammatory agents, antiinfection agents, siRNA, and defatting agents. Numerous animal and clinical studies have examined MP therapeutic agents, some of which have even led to the successful reconditioning of discarded grafts. More clinical studies, especially randomized controlled trials, will need to be conducted in the future to solidify these promising results and to define the role of MP therapeutic agents in solid organ transplantation.<\/jats:p>","DOI":"10.1097\/tp.0000000000003295","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T01:27:26Z","timestamp":1588728446000},"page":"1792-1803","source":"Crossref","is-referenced-by-count":92,"title":["Review of Current Machine Perfusion Therapeutics for Organ Preservation"],"prefix":"10.1097","volume":"104","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Transplantation, UMass Memorial Hospital, University of Massachusetts, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna E.","family":"Buchwald","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Transplantation, UMass Memorial Hospital, University of Massachusetts, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo N.","family":"Martins","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Transplantation, UMass Memorial Hospital, University of Massachusetts, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/00007890-200106270-00011","article-title":"The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival.","volume":"71","author":"Busquets","year":"2001","journal-title":"Transplantation"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.TP.0000149504.53710.AE","article-title":"Outcomes of extended donor lung recipients after lung transplantation.","volume":"79","author":"Kawut","year":"2005","journal-title":"Transplantation"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000499610","article-title":"Organ preservation into the 2020s: the era of dynamic intervention.","volume":"46","author":"Petrenko","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/TP.0000000000002081","article-title":"Ex situ organ preservation: the temperature paradigm.","volume":"102","author":"Rojas-Pena","year":"2018","journal-title":"Transplantation"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1053\/j.gastro.2018.12.037","article-title":"Evolving trends in machine perfusion for liver transplantation.","volume":"156","author":"Dutkowski","year":"2019","journal-title":"Gastroenterology"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/SLA.0000000000003513","article-title":"Novel real-time prediction of liver graft function during hypothermic oxygenated machine perfusion before liver transplantation.","volume":"270","author":"Muller","year":"2019","journal-title":"Ann Surg"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40472-017-0144-y","article-title":"Opportunities for therapeutic intervention during machine perfusion.","volume":"4","author":"Karimian","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jss.2017.11.052","article-title":"Development of pancreatic machine perfusion: translational steps from porcine to human models.","volume":"223","author":"Hamaoui","year":"2018","journal-title":"J Surg Res"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1097\/TXD.0000000000000829","article-title":"Hypothermic oxygenated machine perfusion of the human donor pancreas.","volume":"4","author":"Leemkuil","year":"2018","journal-title":"Transplant Direct"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(97)06405-2","article-title":"Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.","volume":"351","author":"Hosenpud","year":"1998","journal-title":"Lancet"},{"issue":"Suppl 2","key":"R13-20231002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/ajt.15280","article-title":"OPTN\/SRTR 2017 annual data report: deceased organ donation","volume":"19","author":"Israni","year":"2019","journal-title":"Am J Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1164\/rccm.200207-670SO","article-title":"Ischemia-reperfusion-induced lung injury.","volume":"167","author":"de Perrot","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1014597","article-title":"Normothermic ex vivo lung perfusion in clinical lung transplantation.","volume":"364","author":"Cypel","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtcvs.2012.08.009","article-title":"Experience with the first 50 ex vivo lung perfusions in clinical transplantation.","volume":"144","author":"Cypel","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/TP.0000000000000462","article-title":"Clinical outcome of patients transplanted with marginal donor lungs via ex vivo lung perfusion compared to standard lung transplantation.","volume":"99","author":"Fildes","year":"2015","journal-title":"Transplantation"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.healun.2016.04.017","article-title":"Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation.","volume":"35","author":"Mordant","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1073\/pnas.0907996106","article-title":"Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","article-title":"Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.","volume":"187","author":"Lee","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","article-title":"Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.","volume":"306","author":"McAuley","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12931-017-0704-9","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.","volume":"18","author":"Stone","year":"2017","journal-title":"Respir Res"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/ajt.13271","article-title":"Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.","volume":"15","author":"Gennai","year":"2015","journal-title":"Am J Transplant"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/thoraxjnl-2018-211576","article-title":"Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia","volume":"74","author":"Park","year":"2019","journal-title":"Thorax"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13287-017-0603-5","article-title":"Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.","volume":"8","author":"Martens","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-1440-3-19","article-title":"Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study.","volume":"3","author":"La Francesca","year":"2014","journal-title":"Transplant Res"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/TP.0000000000000830","article-title":"Ex vivo perfusion with adenosine A2A receptor agonist enhances rehabilitation of murine donor lungs after circulatory death.","volume":"99","author":"Stone","year":"2015","journal-title":"Transplantation"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.athoracsur.2011.06.062","article-title":"Adenosine A2A agonist improves lung function during ex vivo lung perfusion.","volume":"92","author":"Emaminia","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jtcvs.2015.07.075","article-title":"Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.","volume":"151","author":"Wagner","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.athoracsur.2016.03.041","article-title":"Enteral access is not required for esophageal cancer patients undergoing neoadjuvant therapy.","volume":"102","author":"Huerter","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jtcvs.2017.05.006","article-title":"Which ischemic mitral valves should be repaired and how? Time will tell.","volume":"154","author":"Charles","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.healun.2012.02.001","article-title":"\u03b2-adrenergic agonist infusion during extracorporeal lung perfusion: effects on glucose concentration in the perfusion fluid and on lung function.","volume":"31","author":"Valenza","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.athoracsur.2015.02.136","article-title":"\u03b22-adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung injury.","volume":"100","author":"Kondo","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.athoracsur.2016.07.066","article-title":"Bronchodilator inhalation during ex vivo lung perfusion improves posttransplant graft function after warm ischemia.","volume":"103","author":"Hijiya","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2008.07.027","article-title":"Ex vivo reconditioning of marginal donor lungs injured by acid aspiration.","volume":"27","author":"Inci","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jss.2013.04.043","article-title":"Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.","volume":"184","author":"Inci","year":"2013","journal-title":"J Surg Res"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.TP.0000441320.10787.c5","article-title":"Exogenous surfactant attenuates lung injury from gastric-acid aspiration during ex vivo reconditioning in pigs.","volume":"97","author":"Khalif\u00e9-Hocquemiller","year":"2014","journal-title":"Transplantation"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.healun.2016.11.010","article-title":"Lung lavage and surfactant replacement during ex vivo lung perfusion for treatment of gastric acid aspiration-induced donor lung injury.","volume":"36","author":"Nakajima","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.healun.2007.07.033","article-title":"Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors.","volume":"26","author":"Inci","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.athoracsur.2014.01.076","article-title":"Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system.","volume":"98","author":"Inci","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/hum.2016.070","article-title":"Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model.","volume":"28","author":"Machuca","year":"2017","journal-title":"Hum Gene Ther"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.healun.2013.12.023","article-title":"The effect of ex vivo lung perfusion on microbial load in human donor lungs.","volume":"33","author":"Andreasson","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/ajt.13562","article-title":"Ex vivo perfusion treatment of infection in human donor lungs.","volume":"16","author":"Nakajima","year":"2016","journal-title":"Am J Transplant"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41467-018-08261-z","article-title":"Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.","volume":"10","author":"Galasso","year":"2019","journal-title":"Nat Commun"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"4ra9","DOI":"10.1126\/scitranslmed.3000266","article-title":"Functional repair of human donor lungs by IL-10 gene therapy.","volume":"1","author":"Cypel","year":"2009","journal-title":"Sci Transl Med"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/mt.2012.57","article-title":"Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig.","volume":"20","author":"Yeung","year":"2012","journal-title":"Mol Ther"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/hum.2018.117","article-title":"Immunoengineering of the vascular endothelium to silence MHC expression during normothermic ex vivo lung perfusion.","volume":"30","author":"Figueiredo","year":"2019","journal-title":"Hum Gene Ther"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.healun.2017.09.019","article-title":"\u03b11-Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion.","volume":"37","author":"Lin","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/tri.12823","article-title":"Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation.","volume":"29","author":"Martens","year":"2016","journal-title":"Transpl Int"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jtcvs.2018.02.090","article-title":"Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.","volume":"156","author":"Mehaffey","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R51-20231002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11748-015-0585-0","article-title":"A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion.","volume":"63","author":"Harada","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.","volume":"179","author":"Gupta","year":"2007","journal-title":"J Immunol"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/stem.1504","article-title":"Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice.","volume":"32","author":"Zhu","year":"2014","journal-title":"Stem Cells"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200103013440908","article-title":"Aspiration pneumonitis and aspiration pneumonia.","volume":"344","author":"Marik","year":"2001","journal-title":"N Engl J Med"},{"key":"R56-20231002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ccc.2011.04.005","article-title":"Surfactant therapy for acute lung injury and acute respiratory distress syndrome.","volume":"27","author":"Raghavendran","year":"2011","journal-title":"Crit Care Clin"},{"key":"R57-20231002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc6990","article-title":"Bench-to-bedside review: adenosine receptors\u2013promising targets in acute lung injury?","volume":"12","author":"Schepp","year":"2008","journal-title":"Crit Care"},{"key":"R58-20231002","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jtcvs.2013.01.006","article-title":"Adenosine A1 receptor activation attenuates lung ischemia-reperfusion injury.","volume":"145","author":"Fernandez","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R59-20231002","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jtcvs.2010.03.002","article-title":"Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.","volume":"140","author":"Gazoni","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R60-20231002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jtcvs.2011.06.015","article-title":"Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.","volume":"142","author":"LaPar","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R61-20231002","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.transproceed.2011.01.122","article-title":"The consumption of glucose during ex vivo lung perfusion correlates with lung edema.","volume":"43","author":"Valenza","year":"2011","journal-title":"Transplant Proc"},{"key":"R62-20231002","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/01.CCM.0000129489.34416.0E","article-title":"Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.","volume":"32","author":"McAuley","year":"2004","journal-title":"Crit Care Med"},{"key":"R63-20231002","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.athoracsur.2006.01.010","article-title":"Protective effect of a nebulized beta2-adrenoreceptor agonist in warm ischemic-reperfused rat lungs.","volume":"82","author":"Chen","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"R64-20231002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.healun.2012.03.012","article-title":"The effect of \u03b2-2 adrenoreceptor agonist inhalation on lungs donated after cardiac death in a canine lung transplantation model.","volume":"31","author":"Sakamoto","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R65-20231002","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.healun.2006.07.005","article-title":"Post-mortem administration of urokinase in canine lung transplantation from non-heart-beating donors.","volume":"25","author":"Sugimoto","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R66-20231002","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0003-4975(95)00188-Q","article-title":"Improved lung function by urokinase infusion in canine lung transplantation using non-heart-beating donors.","volume":"59","author":"Umemori","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R67-20231002","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1164\/rccm.201302-0368LE","article-title":"Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation.","volume":"188","author":"Machuca","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R68-20231002","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"R69-20231002","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2213-2600(19)30268-1","article-title":"Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial","volume":"8","author":"Cypel","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R70-20231002","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.15689","article-title":"RNA interference therapeutics in organ transplantation: the dawn of a new era.","volume":"20","author":"Br\u00fcggenwirth","year":"2020","journal-title":"Am J Transplant"},{"key":"R71-20231002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ejcts\/ezv057","article-title":"The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death.","volume":"48","author":"Haam","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"R72-20231002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation.","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"R73-20231002","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/ajt.13708","article-title":"Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial.","volume":"16","author":"Ravikumar","year":"2016","journal-title":"Am J Transplant"},{"key":"R74-20231002","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/lt.24499","article-title":"Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: first North American results.","volume":"22","author":"Selzner","year":"2016","journal-title":"Liver Transpl"},{"key":"R75-20231002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/lt.24751","article-title":"Liver ex situ machine perfusion preservation: a review of the methodology and results of large animal studies and clinical trials.","volume":"23","author":"Marecki","year":"2017","journal-title":"Liver Transpl"},{"key":"R76-20231002","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/TP.0000000000002772","article-title":"Ex situ liver machine perfusion as an emerging graft protective strategy in clinical liver transplantation: the Dawn of a new era.","volume":"103","author":"Nickkholgh","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"R77-20231002","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ajt.15276","article-title":"OPTN\/SRTR 2017 annual data report: liver","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"key":"R78-20231002","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1111\/ajt.15395","article-title":"Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts.","volume":"19","author":"Linares-Cervantes","year":"2019","journal-title":"Am J Transplant"},{"key":"R79-20231002","doi-asserted-by":"crossref","first-page":"e110642","DOI":"10.1371\/journal.pone.0110642","article-title":"Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion.","volume":"9","author":"Sutton","year":"2014","journal-title":"PLoS One"},{"key":"R80-20231002","doi-asserted-by":"crossref","first-page":"e0203803","DOI":"10.1371\/journal.pone.0203803","article-title":"Evolution of dynamic, biochemical, and morphological parameters in hypothermic machine perfusion of human livers: a proof-of-concept study.","volume":"13","author":"Abudhaise","year":"2018","journal-title":"PLoS One"},{"key":"R81-20231002","doi-asserted-by":"crossref","first-page":"e017733","DOI":"10.1136\/bmjopen-2017-017733","article-title":"Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial.","volume":"7","author":"Laing","year":"2017","journal-title":"BMJ Open"},{"key":"R82-20231002","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/TP.0000000000002500","article-title":"Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers.","volume":"103","author":"Matton","year":"2019","journal-title":"Transplantation"},{"key":"R83-20231002","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/SLA.0000000000003540","article-title":"Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial.","volume":"270","author":"van Leeuwen","year":"2019","journal-title":"Ann Surg"},{"key":"R84-20231002","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jhep.2014.04.031","article-title":"Biomarkers to assess graft quality during conventional and machine preservation in liver transplantation.","volume":"61","author":"Verhoeven","year":"2014","journal-title":"J Hepatol"},{"key":"R85-20231002","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/ajt.14687","article-title":"Observations on the ex situ perfusion of livers for transplantation.","volume":"18","author":"Watson","year":"2018","journal-title":"Am J Transplant"},{"key":"R86-20231002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/TP.0b013e318223d817","article-title":"Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.","volume":"92","author":"Jamieson","year":"2011","journal-title":"Transplantation"},{"key":"R87-20231002","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.transproceed.2013.05.005","article-title":"Perfusion defatting at subnormothermic temperatures in steatotic rat livers.","volume":"45","author":"Liu","year":"2013","journal-title":"Transplant Proc"},{"key":"R88-20231002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymben.2009.05.005","article-title":"Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.","volume":"11","author":"Nagrath","year":"2009","journal-title":"Metab Eng"},{"key":"R89-20231002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/TP.0000000000002021","article-title":"Comparison of BQ123, epoprostenol, and verapamil as vasodilators during normothermic ex vivo liver machine perfusion.","volume":"102","author":"Echeverri","year":"2018","journal-title":"Transplantation"},{"key":"R90-20231002","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jss.2013.04.030","article-title":"A new liver graft preparation method for uncontrolled non-heart-beating donors, combining short oxygenated warm perfusion and prostaglandin E1.","volume":"184","author":"Hara","year":"2013","journal-title":"J Surg Res"},{"key":"R91-20231002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/TP.0000000000001127","article-title":"Short oxygenated warm perfusion with prostaglandin E1 administration before cold preservation as a novel resuscitation method for liver grafts from donors after cardiac death in a rat in vivo model.","volume":"100","author":"Maida","year":"2016","journal-title":"Transplantation"},{"key":"R92-20231002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5301\/ijao.5000297","article-title":"Role of vasodilation during normothermic machine perfusion of DCD porcine livers.","volume":"37","author":"Nassar","year":"2014","journal-title":"Int J Artif Organs"},{"key":"R93-20231002","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/ajt.14100","article-title":"Inducing hepatitis C virus resistance after pig liver transplantation-a proof of concept of liver graft modification using warm ex vivo perfusion.","volume":"17","author":"Goldaracena","year":"2017","journal-title":"Am J Transplant"},{"key":"R94-20231002","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0000000000002515","article-title":"First report of siRNA uptake (for RNA interference) during ex vivo hypothermic and normothermic liver machine perfusion.","volume":"103","author":"Gillooly","year":"2019","journal-title":"Transplantation"},{"key":"R95-20231002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/lt.25383","article-title":"Gene silencing with siRNA (RNA interference): a new therapeutic option during ex vivo machine liver perfusion preservation","volume":"25","author":"Thijssen","year":"2019","journal-title":"Liver Transpl"},{"key":"R96-20231002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/lt.24603","article-title":"Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation.","volume":"22","author":"Goldaracena","year":"2016","journal-title":"Liver Transpl"},{"key":"R97-20231002","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/TP.0000000000002123","article-title":"Extracellular vesicles from human liver stem cells reduce injury in an ex vivo normothermic hypoxic rat liver perfusion model.","volume":"102","author":"Rigo","year":"2018","journal-title":"Transplantation"},{"key":"R98-20231002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jss.2019.04.010","article-title":"[D-Ala2, D-Leu5] Enkephalin improves liver preservation during normothermic ex vivo perfusion.","volume":"241","author":"Beal","year":"2019","journal-title":"J Surg Res"},{"key":"R99-20231002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0000000000002461","article-title":"Effect of the selective NLRP3 inflammasome inhibitor mcc950 on transplantation outcome in a pig liver transplantation model with organs from donors after circulatory death preserved by hypothermic machine perfusion.","volume":"103","author":"Yu","year":"2019","journal-title":"Transplantation"},{"key":"R100-20231002","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/SLA.0b013e31815c2a3f","article-title":"Use of severely steatotic grafts in liver transplantation: a matched case-control study.","volume":"246","author":"McCormack","year":"2007","journal-title":"Ann Surg"},{"key":"R101-20231002","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2013.06.017","article-title":"Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu.","volume":"59","author":"Peralta","year":"2013","journal-title":"J Hepatol"},{"issue":"Suppl 2)","key":"R102-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajt.15274","article-title":"OPTN\/SRTR 2017 annual data report: kidney","volume":"19(","author":"Hart","year":"2019","journal-title":"Am J Transplant"},{"key":"R103-20231002","doi-asserted-by":"crossref","first-page":"e5083","DOI":"10.1097\/MD.0000000000005083","article-title":"Maximizing kidneys for transplantation using machine perfusion: from the past to the future: a comprehensive systematic review and meta-analysis.","volume":"95","author":"Hameed","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R104-20231002","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/ajt.12179","article-title":"Renal transplantation after ex vivo normothermic perfusion: the first clinical study.","volume":"13","author":"Nicholson","year":"2013","journal-title":"Am J Transplant"},{"key":"R105-20231002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/ajt.14932","article-title":"Twenty-four-hour normothermic perfusion of discarded human kidneys with urine recirculation.","volume":"19","author":"Weissenbacher","year":"2019","journal-title":"Am J Transplant"},{"key":"R106-20231002","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/bjs.9894","article-title":"Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants.","volume":"102","author":"Hosgood","year":"2015","journal-title":"Br J Surg"},{"key":"R107-20231002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/bjs.10733","article-title":"Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors.","volume":"105","author":"Hosgood","year":"2018","journal-title":"Br J Surg"},{"key":"R108-20231002","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ajt.14491","article-title":"Normothermic ex vivo kidney perfusion for graft quality assessment prior to transplantation.","volume":"18","author":"Kaths","year":"2018","journal-title":"Am J Transplant"},{"key":"R109-20231002","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/tri.13593","article-title":"A systematic review to identify whether perfusate biomarkers produced during hypothermic machine perfusion can predict graft outcomes in kidney transplantation","volume":"33","author":"Guzzi","year":"2020","journal-title":"Transpl Int"},{"key":"R110-20231002","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejphar.2011.03.044","article-title":"Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1\u03b2 in isolated hemoperfused kidneys.","volume":"660","author":"Yang","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"R111-20231002","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/TXD.0000000000000515","article-title":"Cyclic helix B peptide in preservation solution and autologous blood perfusate ameliorates ischemia-reperfusion injury in isolated porcine kidneys.","volume":"1","author":"Yang","year":"2015","journal-title":"Transplant Direct"},{"key":"R112-20231002","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys","volume":"9:eaam6764","author":"Tietjen","year":"2017","journal-title":"Sci Transl Med"},{"key":"R113-20231002","article-title":"Infusing mesenchymal stromal cells into porcine kidneys during normothermic machine perfusion: intact MSCs can be traced and localised to glomeruli","volume":"20:3607","author":"Pool","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R114-20231002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/TP.0000000000002455","article-title":"Potentiating renal regeneration using mesenchymal stem cells.","volume":"103","author":"Brasile","year":"2019","journal-title":"Transplantation"},{"key":"R115-20231002","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/TP.0000000000001437","article-title":"Organ pretreatment with cytotopic endothelial localizing peptides to ameliorate microvascular thrombosis and perfusion deficits in ex vivo renal hemoreperfusion models.","volume":"100","author":"Hamaoui","year":"2016","journal-title":"Transplantation"},{"key":"R116-20231002","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1111\/jcmm.13249","article-title":"Perfusion of isolated rat kidney with mesenchymal stromal cells\/extracellular vesicles prevents ischaemic injury.","volume":"21","author":"Gregorini","year":"2017","journal-title":"J Cell Mol Med"},{"key":"R117-20231002","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000002201","article-title":"CORM-401 reduces ischemia reperfusion injury in an ex vivo renal porcine model of the donation after circulatory death.","volume":"102","author":"Bhattacharjee","year":"2018","journal-title":"Transplantation"},{"key":"R118-20231002","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/TP.0000000000002469","article-title":"Perfusion of porcine kidneys with macromolecular heparin reduces early ischemia reperfusion injury.","volume":"103","author":"Sedigh","year":"2019","journal-title":"Transplantation"},{"key":"R119-20231002","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fimmu.2019.00765","article-title":"Effects of normothermic machine perfusion conditions on mesenchymal stromal cells.","volume":"10","author":"Sierra Parraga","year":"2019","journal-title":"Front Immunol"},{"key":"R120-20231002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/TP.0000000000003032","article-title":"Nanotechnology applications in transplantation medicine","volume":"104","author":"Yao","year":"2019","journal-title":"Transplantation"},{"key":"R121-20231002","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1600-6143.2005.01228.x","article-title":"New cellular and molecular immune pathways in ischemia\/reperfusion injury.","volume":"6","author":"Boros","year":"2006","journal-title":"Am J Transplant"},{"key":"R122-20231002","doi-asserted-by":"crossref","first-page":"100512","DOI":"10.1016\/j.trre.2019.100512","article-title":"Molecular strategies used by hibernators: potential therapeutic directions for ischemia reperfusion injury and preservation of human donor organs.","volume":"34","author":"Soo","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"key":"R123-20231002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.niox.2014.04.008","article-title":"AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.","volume":"41","author":"Szczesny","year":"2014","journal-title":"Nitric Oxide"},{"key":"R124-20231002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.niox.2018.10.004","article-title":"H2S supplementation: a novel method for successful organ preservation at subnormothermic temperatures.","volume":"81","author":"Juriasingani","year":"2018","journal-title":"Nitric Oxide"},{"key":"R125-20231002","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/01.TP.0000093834.05766.FD","article-title":"How to improve the quality of kidneys from non-heart-beating donors: a randomised controlled trial of thrombolysis in non-heart-beating donors.","volume":"76","author":"Gok","year":"2003","journal-title":"Transplantation"},{"key":"R126-20231002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.TP.0000053404.67581.F4","article-title":"Improvement of microvascular graft equilibration and preservation in non-heart-beating donors by warm preflush with streptokinase.","volume":"75","author":"Yamauchi","year":"2003","journal-title":"Transplantation"},{"key":"R127-20231002","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ctr.12121","article-title":"Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline.","volume":"27","author":"Powell","year":"2013","journal-title":"Clin Transplant"},{"key":"R128-20231002","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association.","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"R129-20231002","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.healun.2008.01.025","article-title":"Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector.","volume":"27","author":"Miyagi","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R130-20231002","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/tri.12182","article-title":"Ex vivo intracoronary gene transfer of adeno-associated virus 2 leads to superior transduction over serotypes 8 and 9 in rat heart transplants.","volume":"26","author":"Raissadati","year":"2013","journal-title":"Transpl Int"},{"key":"R131-20231002","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1038\/s41598-019-43737-y","article-title":"A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.","volume":"9","author":"Bishawi","year":"2019","journal-title":"Sci Rep"},{"key":"R132-20231002","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.omtn.2017.10.020","article-title":"Blockade of inflammation and apoptosis pathways by siRNA prolongs cold preservation time and protects donor hearts in a porcine model.","volume":"9","author":"Wei","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"R133-20231002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001563","article-title":"Advancing transplantation: new questions, new possibilities in kidney and liver transplantation.","volume":"101(Suppl 2S)","author":"Wadstr\u00f6m","year":"2017","journal-title":"Transplantation"},{"key":"R134-20231002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/tri.13441","article-title":"The future of organ perfusion and re-conditioning.","volume":"32","author":"Weissenbacher","year":"2019","journal-title":"Transpl Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T09:38:02Z","timestamp":1722850682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":133,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003295","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}